MEI/Kyowa Kirin Show More Data Supporting Zandelisib’s Safety Profile

 
• By Alaric DeArment
  
MEI and Kyowa Kirin presented data at EHA for the PI3K-delta inhibitor zandelisib • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D